Stifel Says Acorda Therapeutics Decline Is 'A Buying Opportunity'
February 11, 2015 at 17:42 PM EST
Stifel commented on Acorda Therapeutics Inc (NASDAQ: ACOR) Wednesday after the stock fell from approximately $40 to $36 Tuesday ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.